- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.25 Å
- Oligo State
- hetero-4-4-mer
- Ligands
- 4 x 01: pemrametostat
01.1: 25 residues within 4Å:- Chain A: F.308, A.309, Y.312, Q.317, L.320, L.327, T.331, Y.332, V.334, F.335, E.336, K.337, K.341, Y.342, E.443, L.445, G.446, S.447, E.452, V.511, F.585, S.586, W.587, F.588
- Ligands: MTA.2
19 PLIP interactions:19 interactions with chain A- Hydrophobic interactions: A:Y.312, A:L.327, A:F.335, A:F.335, A:F.585, A:F.585, A:F.588, A:F.588
- Hydrogen bonds: A:Q.317, A:L.445, A:F.585, A:W.587, A:F.588
- Water bridges: A:Y.312, A:L.320, A:S.447
- Salt bridges: A:E.452
- pi-Stacking: A:F.335
- pi-Cation interactions: A:F.335
01.17: 25 residues within 4Å:- Chain C: F.308, A.309, Y.312, Q.317, L.320, L.327, T.331, Y.332, V.334, F.335, E.336, K.337, K.341, Y.342, E.443, L.445, G.446, S.447, E.452, V.511, F.585, S.586, W.587, F.588
- Ligands: MTA.18
19 PLIP interactions:19 interactions with chain C- Hydrophobic interactions: C:Y.312, C:L.327, C:F.335, C:F.335, C:F.585, C:F.585, C:F.588, C:F.588
- Hydrogen bonds: C:Q.317, C:L.445, C:F.585, C:W.587, C:F.588
- Water bridges: C:Y.312, C:L.320, C:S.447
- Salt bridges: C:E.452
- pi-Stacking: C:F.335
- pi-Cation interactions: C:F.335
01.33: 25 residues within 4Å:- Chain E: F.308, A.309, Y.312, Q.317, L.320, L.327, T.331, Y.332, V.334, F.335, E.336, K.337, K.341, Y.342, E.443, L.445, G.446, S.447, E.452, V.511, F.585, S.586, W.587, F.588
- Ligands: MTA.34
19 PLIP interactions:19 interactions with chain E- Hydrophobic interactions: E:Y.312, E:L.327, E:F.335, E:F.335, E:F.585, E:F.585, E:F.588, E:F.588
- Hydrogen bonds: E:Q.317, E:L.445, E:F.585, E:W.587, E:F.588
- Water bridges: E:Y.312, E:L.320, E:E.452
- Salt bridges: E:E.452
- pi-Stacking: E:F.335
- pi-Cation interactions: E:F.335
01.49: 25 residues within 4Å:- Chain G: F.308, A.309, Y.312, Q.317, L.320, L.327, T.331, Y.332, V.334, F.335, E.336, K.337, K.341, Y.342, E.443, L.445, G.446, S.447, E.452, V.511, F.585, S.586, W.587, F.588
- Ligands: MTA.50
19 PLIP interactions:19 interactions with chain G- Hydrophobic interactions: G:Y.312, G:L.327, G:F.335, G:F.335, G:F.585, G:F.585, G:F.588, G:F.588
- Hydrogen bonds: G:Q.317, G:L.445, G:F.585, G:W.587, G:F.588
- Water bridges: G:Y.312, G:L.320, G:E.452
- Salt bridges: G:E.452
- pi-Stacking: G:F.335
- pi-Cation interactions: G:F.335
- 4 x MTA: 5'-DEOXY-5'-METHYLTHIOADENOSINE(Non-covalent)
- 12 x SO4: SULFATE ION(Non-functional Binders)
SO4.3: 5 residues within 4Å:- Chain A: F.48, V.91, P.128, W.160, Q.271
1 PLIP interactions:1 interactions with chain A- Hydrogen bonds: A:Q.271
SO4.4: 2 residues within 4Å:- Chain A: N.223, R.260
1 PLIP interactions:1 interactions with chain A- Salt bridges: A:R.260
SO4.5: 5 residues within 4Å:- Chain A: Y.206, S.207, K.208, N.490, R.493
4 PLIP interactions:4 interactions with chain A- Hydrogen bonds: A:K.208, A:R.493
- Water bridges: A:H.151
- Salt bridges: A:K.208
SO4.19: 5 residues within 4Å:- Chain C: F.48, V.91, P.128, W.160, Q.271
1 PLIP interactions:1 interactions with chain C- Hydrogen bonds: C:Q.271
SO4.20: 2 residues within 4Å:- Chain C: N.223, R.260
1 PLIP interactions:1 interactions with chain C- Salt bridges: C:R.260
SO4.21: 5 residues within 4Å:- Chain C: Y.206, S.207, K.208, N.490, R.493
4 PLIP interactions:4 interactions with chain C- Hydrogen bonds: C:K.208, C:R.493
- Water bridges: C:H.151
- Salt bridges: C:K.208
SO4.35: 5 residues within 4Å:- Chain E: F.48, V.91, P.128, W.160, Q.271
1 PLIP interactions:1 interactions with chain E- Hydrogen bonds: E:Q.271
SO4.36: 2 residues within 4Å:- Chain E: N.223, R.260
1 PLIP interactions:1 interactions with chain E- Salt bridges: E:R.260
SO4.37: 5 residues within 4Å:- Chain E: Y.206, S.207, K.208, N.490, R.493
4 PLIP interactions:4 interactions with chain E- Hydrogen bonds: E:K.208, E:R.493
- Water bridges: E:H.151
- Salt bridges: E:K.208
SO4.51: 5 residues within 4Å:- Chain G: F.48, V.91, P.128, W.160, Q.271
1 PLIP interactions:1 interactions with chain G- Hydrogen bonds: G:Q.271
SO4.52: 2 residues within 4Å:- Chain G: N.223, R.260
1 PLIP interactions:1 interactions with chain G- Salt bridges: G:R.260
SO4.53: 5 residues within 4Å:- Chain G: Y.206, S.207, K.208, N.490, R.493
4 PLIP interactions:4 interactions with chain G- Hydrogen bonds: G:K.208, G:R.493
- Water bridges: G:H.151
- Salt bridges: G:K.208
- 40 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)
EDO.6: 4 residues within 4Å:- Chain A: Y.543, C.544, T.545
- Chain C: R.108
Ligand excluded by PLIPEDO.7: 11 residues within 4Å:- Chain A: S.329, Q.330, E.333, R.376
- Chain G: D.78, L.79, L.81, S.82, G.83, W.86, L.125
Ligand excluded by PLIPEDO.8: 1 residues within 4Å:- Chain A: H.154
Ligand excluded by PLIPEDO.9: 4 residues within 4Å:- Chain A: K.43, Q.44, G.45, L.289
Ligand excluded by PLIPEDO.10: 6 residues within 4Å:- Chain A: K.103, V.104, E.105, R.108
- Chain B: Y.221, N.242
Ligand excluded by PLIPEDO.11: 8 residues within 4Å:- Chain A: N.120, A.123, Y.124, H.155
- Chain G: N.326, L.327, E.328, N.404
Ligand excluded by PLIPEDO.12: 8 residues within 4Å:- Chain A: I.594, K.595, Q.596, I.598, S.631, A.632, H.634
- Chain C: Q.596
Ligand excluded by PLIPEDO.14: 6 residues within 4Å:- Chain A: R.162
- Chain B: D.133, D.134, K.153, D.154, I.155
Ligand excluded by PLIPEDO.15: 5 residues within 4Å:- Chain B: R.300, S.301, Q.302, A.303
- Ligands: EDO.16
Ligand excluded by PLIPEDO.16: 7 residues within 4Å:- Chain B: F.299, R.300, S.301, A.303, V.331, H.333
- Ligands: EDO.15
Ligand excluded by PLIPEDO.22: 4 residues within 4Å:- Chain A: R.108
- Chain C: Y.543, C.544, T.545
Ligand excluded by PLIPEDO.23: 11 residues within 4Å:- Chain C: S.329, Q.330, E.333, R.376
- Chain E: D.78, L.79, L.81, S.82, G.83, W.86, L.125
Ligand excluded by PLIPEDO.24: 1 residues within 4Å:- Chain C: H.154
Ligand excluded by PLIPEDO.25: 4 residues within 4Å:- Chain C: K.43, Q.44, G.45, L.289
Ligand excluded by PLIPEDO.26: 6 residues within 4Å:- Chain C: K.103, V.104, E.105, R.108
- Chain D: Y.221, N.242
Ligand excluded by PLIPEDO.27: 8 residues within 4Å:- Chain C: N.120, A.123, Y.124, H.155
- Chain E: N.326, L.327, E.328, N.404
Ligand excluded by PLIPEDO.28: 8 residues within 4Å:- Chain A: Q.596
- Chain C: I.594, K.595, Q.596, I.598, S.631, A.632, H.634
Ligand excluded by PLIPEDO.30: 6 residues within 4Å:- Chain C: R.162
- Chain D: D.133, D.134, K.153, D.154, I.155
Ligand excluded by PLIPEDO.31: 5 residues within 4Å:- Chain D: R.300, S.301, Q.302, A.303
- Ligands: EDO.32
Ligand excluded by PLIPEDO.32: 7 residues within 4Å:- Chain D: F.299, R.300, S.301, A.303, V.331, H.333
- Ligands: EDO.31
Ligand excluded by PLIPEDO.38: 4 residues within 4Å:- Chain E: Y.543, C.544, T.545
- Chain G: R.108
Ligand excluded by PLIPEDO.39: 11 residues within 4Å:- Chain C: D.78, L.79, L.81, S.82, G.83, W.86, L.125
- Chain E: S.329, Q.330, E.333, R.376
Ligand excluded by PLIPEDO.40: 1 residues within 4Å:- Chain E: H.154
Ligand excluded by PLIPEDO.41: 4 residues within 4Å:- Chain E: K.43, Q.44, G.45, L.289
Ligand excluded by PLIPEDO.42: 6 residues within 4Å:- Chain E: K.103, V.104, E.105, R.108
- Chain F: Y.221, N.242
Ligand excluded by PLIPEDO.43: 8 residues within 4Å:- Chain C: N.326, L.327, E.328, N.404
- Chain E: N.120, A.123, Y.124, H.155
Ligand excluded by PLIPEDO.44: 8 residues within 4Å:- Chain E: I.594, K.595, Q.596, I.598, S.631, A.632, H.634
- Chain G: Q.596
Ligand excluded by PLIPEDO.46: 6 residues within 4Å:- Chain E: R.162
- Chain F: D.133, D.134, K.153, D.154, I.155
Ligand excluded by PLIPEDO.47: 5 residues within 4Å:- Chain F: R.300, S.301, Q.302, A.303
- Ligands: EDO.48
Ligand excluded by PLIPEDO.48: 7 residues within 4Å:- Chain F: F.299, R.300, S.301, A.303, V.331, H.333
- Ligands: EDO.47
Ligand excluded by PLIPEDO.54: 4 residues within 4Å:- Chain E: R.108
- Chain G: Y.543, C.544, T.545
Ligand excluded by PLIPEDO.55: 11 residues within 4Å:- Chain A: D.78, L.79, L.81, S.82, G.83, W.86, L.125
- Chain G: S.329, Q.330, E.333, R.376
Ligand excluded by PLIPEDO.56: 1 residues within 4Å:- Chain G: H.154
Ligand excluded by PLIPEDO.57: 4 residues within 4Å:- Chain G: K.43, Q.44, G.45, L.289
Ligand excluded by PLIPEDO.58: 6 residues within 4Å:- Chain G: K.103, V.104, E.105, R.108
- Chain H: Y.221, N.242
Ligand excluded by PLIPEDO.59: 8 residues within 4Å:- Chain A: N.326, L.327, E.328, N.404
- Chain G: N.120, A.123, Y.124, H.155
Ligand excluded by PLIPEDO.60: 8 residues within 4Å:- Chain E: Q.596
- Chain G: I.594, K.595, Q.596, I.598, S.631, A.632, H.634
Ligand excluded by PLIPEDO.62: 6 residues within 4Å:- Chain G: R.162
- Chain H: D.133, D.134, K.153, D.154, I.155
Ligand excluded by PLIPEDO.63: 5 residues within 4Å:- Chain H: R.300, S.301, Q.302, A.303
- Ligands: EDO.64
Ligand excluded by PLIPEDO.64: 7 residues within 4Å:- Chain H: F.299, R.300, S.301, A.303, V.331, H.333
- Ligands: EDO.63
Ligand excluded by PLIP- 4 x PEG: DI(HYDROXYETHYL)ETHER(Non-functional Binders)
PEG.13: 5 residues within 4Å:- Chain A: F.414, E.416, W.417, G.418, S.419
1 PLIP interactions:1 interactions with chain A- Hydrogen bonds: A:S.419
PEG.29: 5 residues within 4Å:- Chain C: F.414, E.416, W.417, G.418, S.419
1 PLIP interactions:1 interactions with chain C- Hydrogen bonds: C:S.419
PEG.45: 5 residues within 4Å:- Chain E: F.414, E.416, W.417, G.418, S.419
1 PLIP interactions:1 interactions with chain E- Hydrogen bonds: E:S.419
PEG.61: 5 residues within 4Å:- Chain G: F.414, E.416, W.417, G.418, S.419
1 PLIP interactions:1 interactions with chain G- Hydrogen bonds: G:S.419
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Cottrell, K.M. et al., MTA-Cooperative PRMT5 Inhibitors: Mechanism Switching Through Structure-Based Design. J.Med.Chem. (2025)
- Release Date
- 2025-03-05
- Peptides
- Protein arginine N-methyltransferase 5: ACEG
Methylosome protein 50: BDFH - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AC
AE
AG
AB
BD
BF
BH
B
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.25 Å
- Oligo State
- hetero-4-4-mer
- Ligands
- 4 x 01: pemrametostat
- 4 x MTA: 5'-DEOXY-5'-METHYLTHIOADENOSINE(Non-covalent)
- 12 x SO4: SULFATE ION(Non-functional Binders)
- 40 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)
- 4 x PEG: DI(HYDROXYETHYL)ETHER(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Cottrell, K.M. et al., MTA-Cooperative PRMT5 Inhibitors: Mechanism Switching Through Structure-Based Design. J.Med.Chem. (2025)
- Release Date
- 2025-03-05
- Peptides
- Protein arginine N-methyltransferase 5: ACEG
Methylosome protein 50: BDFH - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AC
AE
AG
AB
BD
BF
BH
B